Up to 14,000 patients living with the autoimmune disease could benefit from NICE’s decision
The roll out follows NICE’s recommendation of the treatment in October 2023
More than 35,000 cases of the blood cancer are expected to be diagnosed in the US this year
AMR is designated by the World Health Organization as one of the top ten threats to global health
NN-8828 has been developed up to phase 2 in non-dermatological indications